title: Chromosomal alterations in early stages of malignant mesotheliomas.
abstract: In a case of a 67-year-old man with two different early stages of a predominantly epithelioid mesothelioma ("mesothelioma in situ", "early-stage mesothelioma"), chromosomal imbalances were determined by comparative genomic hybridisation (CGH), a molecular cytogenetic technique to detect chromosomal gains and losses in tumour cells. In the case of the mesothelioma in situ cells, nine different chromosomal alterations could be detected (losses on 3p, 5q, 6q, 8p, 9p, 15q, 22q, Y; gain on 7q), whereas the early-stage mesothelioma showed the same defects except for the gain on 7q. The simultaneous losses of 6q, 9p and 22q, as well as other chromosomal regions, correlate well with the most common defects previously found in 90 cases of more-advanced-stage mesotheliomas using CGH. These data demonstrate that initial chromosomal defects in early stages of mesotheliomas can be detected by conventional CGH in combination with laser microdissection. The molecular cytogenetic findings support the histological diagnosis of a pleural mesothelioma. The surprisingly high number and extent of genomic alterations found in the examined case probably reflects the genomic instability in the tumour cells and indicates a "genetic chaos" even in earlier stages of malignant mesotheliomas.
authors: Institut für Pathologie der Ruhr-Universität Bochum an den Berufsgenossenschaftlichen Kliniken Bergmannsheil, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany. simon-franky@t-online.de
authors: Frank
authors: F
authors: Simon
authors: Georg
authors: G
authors: Johnen
authors: Michael
authors: M
authors: Krismann
authors: Klaus-Michael
authors: KM
authors: Müller
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis; D002869:Chromosome Aberrations; D004273:DNA, Neoplasm / Q000235:genetics*; D006801:Humans; D007150:Immunohistochemistry; D007834:Lasers; D008297:Male; D008654:Mesothelioma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D042282:Microdissection; D009693:Nucleic Acid Hybridization; D010996:Pleural Effusion / Q000473:pathology; D010997:Pleural Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D016133:Polymerase Chain Reaction
chemical_list: D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm